Rocket Pharmaceuticals
RCKT
RCKT
164 hedge funds and large institutions have $1.1B invested in Rocket Pharmaceuticals in 2022 Q3 according to their latest regulatory filings, with 31 funds opening new positions, 64 increasing their positions, 40 reducing their positions, and 14 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
12% more funds holding
Funds holding: 147 → 164 (+17)
6.17% more ownership
Funds ownership: 98.41% → 104.58% (+6.2%)
0% more funds holding in top 10
Funds holding in top 10: 3 → 3 (0)
Holders
164
Holding in Top 10
3
Calls
$10.2M
Puts
$902K
Top Buyers
| 1 | +$13.9M | |
| 2 | +$13.7M | |
| 3 | +$8.52M | |
| 4 |
BlackRock
New York
|
+$7.8M |
| 5 |
ABG
Ally Bridge Group
New York
|
+$7.65M |
Top Sellers
| 1 | -$11.2M | |
| 2 | -$10.6M | |
| 3 | -$4.93M | |
| 4 |
SCM
Soleus Capital Management
Greenwich,
Connecticut
|
-$4.68M |
| 5 |
Federated Hermes
Pittsburgh,
Pennsylvania
|
-$4.42M |